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Organic  selenium  compounds  possess  numerous  biological  properties,  including  antioxidant  activity.  Yet,
the high  toxicity  of  some  of  them,  such  as  diphenyl  diselenide  (DPDS),  is  a limiting  factor  in  their  current
usage.  Accordingly,  we  tested  four  novel  organic  selenium  compounds  in the  non-parasite  nematode
Caenorhabditis  elegans  and  compared  their  efﬁcacy  to  DPDS.  The  novel  organic  selenium  compounds
are  -selenoamines  1-phenyl-3-(p-tolylselanyl)propan-2-amine  (C1)  and  1-(2-methoxyphenylselanyl)-
3-phenylpropan-2-amine  (C2)  and analogs  of  DPDS  1,2-bis(2-methoxyphenyl)diselenide  (C3)  and  1,2-
bisp-tolyldiselenide  (C4).  Synchronized  worms  at the L4  larval  stage  were  exposed  for  one  hour  in  M9
buffer  to these  compounds.  Oxidative  stress  conditions  were  induced  by juglone  (200  M)  and  heat shock
(35 ◦C).  Moreover,  we evaluated  C. elegans  behavior,  GST-4::GFP  (glutathione  S-transferase)  expression
and  the  activity  of  acetylcholinesterase  (AChE).  All  tested  compounds  efﬁciently  restored  viability  in
juglone  stressed  worms.  However,  DPDS,  C2,  C3  and  C4  signiﬁcantly  decreased  the  defecation  cycle
time.  Juglone-induced  GST-4::GFP  expression  was  not  attenuated  in  worms  pretreated  with  the  novel
compounds,  except  with  C2.  Finally,  AChE  activity  was  reduced  by DPDS,  C2,  C3 and  C4.  To our  knowledge,
this  is  study  ﬁrstly  showed  the  effects  of  C1,  C2,  C3 and  C4 selenium-derived  compounds  in  C. elegans.  Low
toxic  effects  were  noted,  except  for reduction  in  the  defecation  cycle,  which  is likely  associated  with  AChE
inhibition.  The  juglone-induced  stress  (reduced  viability)  was  fully  reversed  by compounds  to  control
animal  levels.  C2 was  also  efﬁcient  in  reducing  the  juglone-induced  GST-4::GFP  expression,  suggesting
the  latter  may  mediate  the  stress  induced  by  this  compound.  Future  studies  could  be proﬁtably  directed
at  addressing  additional  molecular  mechanisms  that  mediate  the  protective  effects  of  these  novel  organic
selenium  compounds.
©  2015  Published  by Elsevier  Ireland  Ltd.  This  is an  open  access  article  under  the  CC  BY-NC-ND. IntroductionOrganic selenium compounds have been recognized for
heir immunosuppressive, anti-inﬂammatory, anti-cancer, anti-
epressive, as well as neuro, cardio and hepatoprotective activities
∗ Corresponding author. Fax: +55 55 3220 8978.
E-mail address: felix@ufsm.br (F.A.A. Soares).
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214-7500/© 2015 Published by Elsevier Ireland Ltd. This is an open access article under license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
in a myriad of diseases associated with increased oxidative stress
conditions [1]. Two of the main studied selenium-containing com-
pounds, ebselen and diphenyl diselenide (DPDS), possess strong
antioxidant activity, which has been associated with their abil-
ity to mimic  glutathione peroxidase-like activity (GPx), as well
as also by acting as substrates of thioredoxin reductase (TrxR)
[1,2]. Nevertheless, the toxicity of these molecules has limited
their usage for pharmacological purposes in vertebrate animals
[3]. Their toxicity is primarily characterized by enzymatic inhi-
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
9 ology Reports 2 (2015) 961–967
b
d
d
p
s
1
m
a
1
h
a
h
u
A
s
a
t
i
[
M
p
i
p
r
h
a
2
2
p
p
(
a
a
g
o
p
(
2
4
C
A
2
1
O
u
g
2
c
t
w
W
a
w
Fig. 1. Chemical structure and nomenclature of the -selenoamines (C1 and C2),62 S.T. Stefanello et al. / Toxic
ition of acetylcholinesterase (AChE) and -aminolevulinic acid
ehydratase (-ALA-D) [3,4]. Accordingly, the need exists for the
evelopment of novel organic selenium compounds that provide
harmacological efﬁcacy absent toxicity.
The present study focused on two different classes of organic
elenium compounds, namely, monoselenides or -selenoamines
-phenyl-3-(p-tolylselanyl)propan-2-amine (C1) and 1-(2-
ethoxyphenylselanyl)-3-phenylpropan-2-amine (C2) and
nalogs of DPDS 1,2-bis(2-methoxyphenyl) diselenide (C3) and
,2-bisp-tolyldiselenide (C4). These novel mono and diselenides
ave already been shown to possess antioxidant properties in vitro,
ssociated with the the selenol formation [5].
The non-parasite nematode Caenorhabditis elegans (C. elegans)
as been extensively used in toxicology, pharmacology and molec-
lar biology studies, predominantely given its genetic power [6].
mongst its many advantages are short life cycle, transparency,
tereotypical development, compact genome, ease of breeding
nd small size [7]. Selenium compounds have been studied in
his model, addressing their efﬁcacy against oxidative stress-
nduced toxicity and attenuation of A1-42 (amyloid-)  expression
8]. Seleno-xylofuranosides have also been shown to attenuate
n-induced toxicity, by regulating the DAF-16/FOXO signaling
athway, and ebselen was shown to be effective in reversing Mn-
nduced reduction in survival and lifespan in C. elegans [9,10].
Here, we assessed the toxicity of novel organic selenium com-
ounds and DPDS in C. elegans. We  evaluated survival, behavior,
eproduction and AChE activity in response to oxidative stress and
eat shock, addressing the efﬁcacy of these novel compounds in
ttenuating toxicity.
. Materials and methods
.1. Organic selenium compounds
The organic selenium compounds 1-phenyl-3-(p-tolylselanyl)
ropan-2-amine (C1), 1-(2-methoxyphenylselanyl)-3-
henylpropan-2-amine (C2), 1,2-bis (2-methoxyphenyl) diselenide
C3), and 1,2-bisp-tolyldiselenide (C4) (Fig. 1) were synthesized
ccording to Salman et al. and the chemical purity (99.9%) was
ssessed by hydrogen and carbon nuclear magnetic resonance and
as chromatography [11]. We  compared the toxicity and efﬁcacy
f these novel compounds with a classical organic selenium com-
ound, DPDS. All compounds were dissolved in dimethyl sulfoxide
DMSO).
.2. Worm maintenance
C. elegans Bristol N2 (wild-type) and CL2166 (N2; dvIs19 (Pgst-
::gfp; rol-6), glutathione S-transferase), were provided by the
aenorhabditis Genetic Center (CGC, University of Minnesota).
ll strains were grown at 20 ◦C on NGM plates (1.7% agar,
.5 mg  mL-1peptone, 25 mM NaCl, 50 mM KH2PO4 pH 6.0, 5 g mL-
 cholesterol, 1 mM CaCl2, 1 mM MgSO4) with fresh Escherichia coli
P50 as food source [12]. For each experiment, synchronized pop-
lations were obtained by disruption of gravid adults. Worms  were
rown to the L4 larval stage on NGM/OP50-seeded plates.
.3. C. elegans experimental treatments
L4 larval stage worms were exposed to the organic selenium
ompounds for one hour at different concentrations. Worms  were
ransferred to a 1.5 mL  conical tubes containing M9  buffer along
ith each of the compounds or DMSO (vehicle, at 1% maximum).
orms  were kept under constant shaking for oxygenation during
ll phases of the liquid treatments. After one hour, animals were
ashed three times with M9  and transferred to NGM plates seededdiphenyl diselenide (DPDS) and analogs (C3 and C4).
with OP50. Worms  were left for 30 min  to acclimate on the plates
prior to the behavioral assays, and for twenty-four hours for the
survival assay and reproductive proﬁle assessments.
2.4. Concentration range
Survival curves were generated for treatment (twenty-four
hours) at 5, 25, 50, 100, 200 and 400 M.  Worms  were consid-
ered dead when no movement response was obtained upon gentle
touch and/or pharyngeal pumping was unnoted. Four experiments
were individually performed in duplicates with approximately one
hundred worms  per treatment. After performing the dose-response
curve for each of the organic selenium compounds, we  chose the
non-toxic dose of 200 M for further assays (mentioned below).
2.5. Pharyngeal pumping
Pharyngeal pumping was  individually veriﬁed for ten seconds
at three time points in animals seeded over bacteria at 22 ± 2 ◦C
[13]. The results were expressed as pharyngeal pumping/min. Ten
worms were used in each experiment, with three independent
replicates.
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.6. Defecation cycle
After treatment with organic selenium compounds, animals
ere washed with M9  and transferred to a fresh NGM plate seeded
ith E. coli OP50 [13]. The mean of three defecation cycles from
ach animal was used as indirect measurement of intestinal trafﬁc.
his experimental procedure was performed at 22 ± 2 ◦C with ten
orms, and independently replicated in triplicate worm prepara-
ions.
.7. Reproductive proﬁle
C. elegans reproductive proﬁle was analyzed twenty four hours
fter treatment. Egg-production represents the amount of eggs
nside the uterus in each animal and egg-laying is represents the
verage of eggs laid over two hours. The results were expressed
s the number of eggs/worm and eggs/worm/2 h respectively. Ten
orms were used in each experiment, and independently repli-
ated in triplicate worm preparations.
.8. Body bends
L4 treated worms were individually transferred to E.coli-free
GM plates and allowed to move freely. After one min of adapta-
ion, the number of body bends was scored in a 60-s time interval.
 body bend was deﬁned as a direction change in propagation of
he posterior pharynx bulb along the y-axis, assuming the worm
as traveling along the x axis [14]. Ten worms were observed at
2 ± 2 ◦C, and each experiment was independently replicated in
riplicate worm preparations.
.9. AChE activity
AChE activity in N2 L4 larval stage worms was  analyzed with
 colorimetric assay [15] with some modiﬁcations [16]. Follow-
ng exposure to the organic selenium compounds, animals were
ashed three times in M9  buffer and transferred to microcen-
rifuge tubes. The samples were frozen three times in liquid
itrogen prior to sonication 9 × 10-s with 10-s breaks on ice at 30%
mplitude, spun for 30 min  at 15,000 rpm, and the supernatants
lysates) collected. Protein content was determined as previously
escribed [17] with bovine serum albumin (BSA) as standard. A
60-L portion of the sample was mixed with 1200 L of 0.25 mM
,5-dithiobis (2-nitrobenzoic acid) (DTNB), and 40 L of 156 mM
cetylthiocholine iodide (ASChI) and incubated at 30 ◦C for 5 min.
he rate of change in absorbance was measured at 405 nm at 30-s
ntervals for one min  by spectrophotometry. Kinetic measurements
ere recorded and converted to total cholinesterase activity using
he extinction coefﬁcient for the colored product, 5-thio-2-nitro-
enzoic acid (II) [15]. Experiments were performed in duplicates
n three different days with ∼500 worms per group.
.10. Survival assay over juglone-induced oxidative stress
Worms  at the L4 larval stage were treated with 200 M of each
ompound as described above (∼500 worms per group). After three
ashes in M9,  the worms were picked and transferred to tubes
ontaining 100 M juglone (5-hydroxy-1,4-naphthoquinone) or
thanol (EtOH, 1% maximum) [8]. After one hour of exposure under
onstant shaking, the worms were washed again with M9  and
ransferred to NGM plates where survival was examined twenty
our hours later following the same criteria described above.eports 2 (2015) 961–967 963
2.11. Stress induction of the GST-4 promoter
Worms  at L4 larval stage were treated with each of the com-
pounds (200 M)  for one hour and gently washed in M9 buffer.
Next, animals were treated for one hour with juglone (50 M)
followed by three washes with M9,  and transferred to a black
microplate. For each measurement, twenty adult hermaphrodites
were assessed for GFP ﬂuorescence with a SpectraMax® i3 Multi-
Mode Microplate Reader. Prior to the analysis, worms were
concentrated in the middle of the wells by gently shaking the
plate. GFP excitation was performed at 488 nm and emission was
measured at 525 nm.  In addition, a sample of treated worms was
microscopically examined with an Olympus IX81 Inverted Micro-
scope at 20× magniﬁcation using the green ﬁlter for ﬂuorescence.
The results were expressed as Arbitrary Fluorescence Units (AFU).
2.12. Heat shock stress
After pre-treatment with organic selenium compounds, worms
were kept for four hours on food at 35 ◦C as a stress condition. Sur-
vival was assessed consecutively each hour during the heat shock,
and results were expressed as% of survival (of a total of 100 worms
per treatment). Approximately one hundred worms  were counted
per group in each independent experiment. Each experiment was
independently replicated in triplicate worm preparations.
2.13. Minimum inhibitory concentration (MIC) in E. coli OP50
To verify whether the organic selenium compounds has inﬂu-
ence on E.coli OP50 growth, we assessed the MIC. Bacteria was
seeded on plates with Mueller Hinton agar and allowed to grow
for twenty four hours at 37 ◦C. Next, we  prepared suspensions of
microorganisms in Mueller Hinton broth. The MIC  was performed
according to Clinical and Laboratory Standards Institute [18]. A total
of 50 L of the standardized microorganism suspension was placed
in each test well of a 96-well microtiter plate, along with an equal
volume of compound to be tested at different concentrations. We
performed a broth control, a growth control, and a compound vehi-
cle control to which the results were compared. The plates were
incubated for twenty four hours at 37 ◦C. The MIC  was considered
as the lowest concentration of the test product able to inhibit the
growth of microorganisms evidenced by the use of 2,3,5 triphenyl-
tetrazolium chloride 1%.
2.14. Protein quantiﬁcation
Protein concentration was estimated by the Bradford method
with bovine serum albumin as the standard [17].
2.15. Statistical analysis
All data are expressed as means ± S.E.M for each experimental
group. Determination of statistical signiﬁcance was performed by
one-way analysis of variance (ANOVA) followed by Newman–Keuls
Multiple Comparison Test where appropriate. Differences between
groups were considered to be signiﬁcant at p < 0.05.
3. Results
3.1. C. elegans behavior under organic selenium compounds
exposurePre-treatment with DPDS and the organic selenium compounds
did not interfere with C. elegans egg-laying, egg-production, pha-
ryngeal pumping and body bends (data not shown). However,
964 S.T. Stefanello et al. / Toxicology Reports 2 (2015) 961–967
Fig. 2. C. elegans behavior upon treatment with novel organic selenium compound.
Intervals of defecation cycles (s) were assessed at the L4 larval stage 30 min
after the compoundsı´ exposure on NGM plates. * indicates statistical signiﬁcance
(p  < 0.05) compared to the control group by means of one-way ANOVA followed
by Newman–Keuls Multiple Comparison Test (mean ± SEM). Ten animals were
observed in three independent experiments.
Fig. 3. AChE enzyme activity was signiﬁcantly reduced by treatment with novel
organic selenium compounds, except C1, in C. elegans.
The activity of AChE was  studied in L4 larval stage worms  following novel organic
s
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Fig. 4. C. elegans survival was not affected by 200 M treatment with novel organic
selenium compounds.
Worms  were treated with each of the compounds for 1 h or vehicle (DMSO for
organic selenium compound, EtOH for juglone and M9 buffer for control). After three
washes in M9,  the worms were transferred to NGM plates and the viability assessed
24 h later. Results are shown as% of survival of total worms (mean ± SEM) of threeelenium compound treatment. * indicates statistical signiﬁcance (p < 0.05) com-
ared to the control group with one-way ANOVA followed by Newman–Keuls
ultiple Comparison Test (mean ± SEM). Five hundred animals were used in three
ndependent experiments.
reatment with the organic selenium compounds, excepted C1 pro-
uce a signiﬁcantly decreased the defecation cycle when compared
o non-treated worms (Fig. 2).
.2. C. elegans AChE activity following exposure to organic
elenium compounds
C2, DPDS, C3 and C4 signiﬁcantly diminished AChE activity
p < 0.05), compared to the control group, (Fig. 3). C1, which con-
ains a p-methyl inclusion, failed to alter AChE activity. The absolute
ontrol value was 41.34 ± 1.67 mol/min/mg protein.
.3. Organic selenium compounds protect against
uglone-induced oxidative stress
Juglone treatment signiﬁcantly decreased the survival rate
n C. elegans (Fig. 4, p < 0.05 compared to the control worms).independent experiments. * indicates statistical signiﬁcance (p < 0.05) compared
to  the control group with one-way ANOVA followed by Newman-Keuls Multiple
Comparison Test.
Pre-treatment with DPDS or the organic selenium compounds
protected the worms against juglone-induced toxicity, restoring
viability to levels indistinguishable from controls.
3.4. Effect of organic selenium compounds on the GST-4 promoter
ﬂuorescence
The ﬂuorescence of GST-4::GFP transgenic worms was  quan-
tiﬁed after pre-treatment with organic selenium compounds
followed by juglone stress induction (Fig. 5A and B). In addition,
only C2 was  able to prevent the juglone-induced GST-4 increase in
ﬂuorescence (p < 0.05, C2 in comparison to juglone treated group).
3.5. Organic selenium compounds protect against heat shock
stress
The heat shock stress produced a time-dependent decrease in
worm survival. In addition, treatment with mono- or diselenides
failed to increase C. elegans viability over the heat shock induced
stress (data not shown).
3.6. Effects of organic selenium compounds on E. coli OP50
The organic selenium compounds did not cause a signiﬁcant
antimicrobial effect on E. coli OP50 growth. In addition, all com-
pounds tested at a concentration range between 5 and 400 M
showed analogous levels to the positive bacteria control group
(data not shown).
4. Discussion
A number of organic selenium compounds have been studied,
assessing their efﬁcacy in attenuating oxidative stress generation
[3,19]. Their antioxidant capacity is predominantly ascribed to their
mimetic activity of endogenous antioxidant enzymes, as well as the
production of selenol group [20,21]. Nevertheless, several studies
have also reported enhanced toxicity inherent to these organic sele-
nium compounds, likely related to the catalytic oxidation of thiol
S.T. Stefanello et al. / Toxicology Reports 2 (2015) 961–967 965
Fig. 5. GST-4::GFP expression is induced by juglone and suppressed by the C2 organic selenium compound.
Worms were pre-treated with each of the compounds for 1 h (200 M),  washed three times in M9  and subjected to juglone treatment (200 M)  for 1 h. GST-4::GFP ﬂuorescence
was  microscopically evaluated with an Olympus IX81 Inverted Microscope at 20× magniﬁcation, using the green ﬁlter for ﬂuorescence (A) and with the SpectraMax® i3
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ompared to the juglone treated group. Analysis was  carried out by means of one-w
nimals were observed in four independent experiments.
roups from glutathione (GSH) or different proteins and enzymes
1,3]. Accordingly, the search for efﬁcacious organic compounds has
et to materialized.
Herein, structural modiﬁcations to classical selenium com-
ounds, i.e., ebselen and DPDS, were made to synthesize novel
olecules with inherent capacity to produce selenol groups, higher
tability and low toxicity [21,22]. Our group has shown that -
elenoamines and anologs of DPDS possess enhanced in vitro
ntioxidant properties, such as a signiﬁcant elevation in both GPx
nd TRxR activity [5,23]. In this regard, we assessed biological and
oxicological activities of these novel organic selenium compounds
in comparison with DPDS) in the C. elegans model.
To the best of our knowledge, this is the ﬁrst trial study which
ddressed the effects of these novel organic selenium compounds
1, C2, C3 and C4 on a whole organism. Our studies suggest lack of
ffects of these compounds on C. elegans survival at doses as high as
00 M (data not shown). Furthermore, the novel organic seleniumce compared to control and * indicates statistically signiﬁcant (p < 0.05) difference
OVA followed by Newman–Keuls Multiple Comparison Test (mean ± SEM). Twenty
compounds did not affect reproduction, feeding and movement
behaviors (data not shown). Interestingly, we  observed DPDS-, C2-,
C3- and C4-induced decrease on the frequency of defecation cycles
(Fig. 2). This behavior is a stereotypic motor program that in the
nematode occurs approximately every 50 s [24]. Each cycle begins
with a posterior body contraction that drives gut contents to the
anterior part of the worm and is followed by an anterior body
muscle contraction that pushes expels the gut contents toward the
posterior of the animal, followed by an enteric muscle contraction
that expels gut contents [7]. Among many pathways which orches-
trate the defecation motor program in C. elegans [7], we afﬁrmed
herein that novel selenium compounds interfere with choliner-
gic system (Fig. 3). The neurotransmitter ACh has been found at
low ranges in cha-1 mutants (cha-1 choline acetyltransferase) [25],
which exhibit an increase in the interval between defecation cycles.
The tested compounds, except C1, caused a signiﬁcant reduction in
the AChE activity (Fig. 3), suggests that greater availability of synap-
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ic ACh is responsible for the noted decrease the defecation cycle
ime. Furthermore, C1 could not diminish the AChE activity (Fig. 3),
hich corroborates with the absence of effects over defecation
ycle interval (Fig. 2). The AChE reduction caused by selenium com-
ounds, such as ebselen and DPDS, have been also been reported
n previous studies using rat brains in vitro and mouse ex vivo,
espectively [26,27].
We  further characterized whether the novel organic sele-
ium compounds attenuated juglone-induced stress. Our ﬁndings
emonstrate that juglone reduced the worms’ viability by ∼50%,
nd that pre-treatment with organic selenium compounds fully
bolished this effect to levels indistinguishable from controls. This
ffect was inherent to all the tested novel organic selenium com-
ounds, showing full protection against juglone-induced toxicity
Fig. 4).
Juglone is a reactive oxygen-generating naphthoquinone and
t has been previously studied in C. elegans to deﬁne genes that
romote oxidative stress resistance [28,29]. Among many stress-
elated genes, gst-4 is upregulated upon juglone exposure [30].
ur data corroborate the ability of juglone to potently induce GST-
::GFP expression, an effect which was signiﬁcantly reduced by
2 (Fig. 5). C2’s efﬁcacy in attenuating juglone-induced stress may
hus reﬂect its ability to increase GST-4 levels. DPDS, C1, C3 and
4 failed to decrease GST-4::GFP ﬂuorescence even at doses that
igniﬁcantly reduced juglone toxicity (Fig. 4). Juglone can induce
xidative stress through various mechanism, such as superoxide
O2−•), hydroxyl radical (•OH) and hydrogen peroxide (H2O2) for-
ation, triggering toxic effects by protein modiﬁcations [31,32],
ipid oxidation [33] and nuclear DNA damage [34]. Earlier studies
rom our group have demonstrated that DPDS analogs were able
o protect against thioacetamide-induced oxidative stress in mice
35]. However, further studies are needed to verify the effects of the
ovel organic selenium compounds via an analogous mechanism
n C. elegans.
Organic selenium compounds are known to possess antimi-
robial activity [36]. Accordingly, we performed the minimum
nhibitory concentration (MIC) of these compounds in E. coli OP50
o ascertain whether they might cause a decrease bacterial viability,
nd thus interfere in the worms’ lifespan. Our results established
hat neither of the novel organic selenium compounds at concen-
ration tested can diminish the E. coli OP50 quality, which provide
urther impetus for future studies regarding C. elegans development
nd lifespan.
In conclusion, we have demonstrated that structural changes
ade in the C1, C2, C3 and C4 organic selenium compounds pre-
ented juglone-induced stress in C. elegans,  mimicking the efﬁcacy
f DPDS. Furthermore, our ﬁndings indicate that C1, in addition to
ossessing high efﬁcacy against juglone-invoked stress, also main-
ained optimal AChE activity and normal defecation cycle in the
orm. This effect may  reﬂect the presence of amino group and p-
ethyl insertions in the C1 molecule. Combined, these ﬁndings
uggest the novel organic selenium compounds have promising
harmacological properties in attenuating oxidative stress condi-
ions. Future studies could be proﬁtably directed at deciphering
heir efﬁcacy in other animal models and establishing the molecular
echanisms inherent to this protection.
onﬂict of interest
The authors report no ﬁnancial or other conﬂict of interest rel-
vant to the subject of this article.cknowledgments
This work was carried out with funds from Conselho
acional de Desenvolvimento Cientíﬁco e Tecnológico (CNPq
[Reports 2 (2015) 961–967
Universal #472669/2011-7 and #475896/2012-2), Coordenac¸ ão de
Aperfeic¸ oamento de Pessoal de Nível Superior (CAPES for providing
fellowship to S.T.S. and P.G.) and Fundac¸ ão de Amparo à Pesquisa do
Estado do Rio Grande do Sul (Programa de Apoio a Núcleos emer-
gentes - PRONEM/FAPERGS #11/2029-1, for providing fellowship
to B.P.). Prof. Michael Aschner was supported in part by grants from
the National Institute of Environmental Health Sciences (NIEHS)
R01 ES10563 and R01 ES 07731.
References
[1] C.W. Nogueira, G. Zeni, J.B.T. Rocha, Organoselenium and organotellurium
compounds: toxicology and pharmacology, Chem. Rev. 104 (12) (2004)
6255–6286.
[2] B.K. Sarma, G. Mugesh, Antioxidant activity of the anti-inﬂammatory
compound ebselen: a reversible cyclization pathway via selenenic and
seleninic acid intermediates, Chemistry 14 (34) (2008) 10603–10614.
[3] C. Nogueira, J.T. Rocha, Toxicology and pharmacology of selenium: emphasis
on synthetic organoselenium compounds, Arch. Toxicol. 85 (11) (2011)
1313–1359.
[4] H.G. Mautner, Isologous oxygen, sulfur, and selenium compounds as probes of
acetylcholine receptors, J. Gen. Physiol. 54 (1) (1969) 271–277.
[5] S.T. Stefanello, et al., Evaluation of in vitro antioxidant effect of new mono and
diselenides, Toxicol. In Vitro 27 (5) (2013) 1433–1439.
[6] M.C.K. Leung, et al., Caenorhabditis elegans: an emerging model in biomedical
and environmental toxicology, Toxicol. Sci. 106 (1) (2008) 5–28.
[7] D.L. Riddle, T. Blumenthal, B.J. Meyer, J.R. Priess, Introduction to C. elegans, in:
D.L. Riddle, T. Blumenthal, B.J. Meyer, J.R. Priess (Eds.), C. elegans II, Cold
Spring Harbor Laboratory Press, Plainview, New York, 1997, pp. 1–22.
[8] D.C. Zamberlan, et al., Diphenyl-diselenide suppresses amyloid- peptide in
Caenorhabditis elegans model of Alzheimer’s disease, Neuroscience 278 (0)
(2014) 40–50.
[9] D.S. Avila, et al., Organotellurium and organoselenium compounds attenuate
Mn-induced toxicity in Caenorhabditis elegans by preventing oxidative stress,
Free Radic. Biol. Med. 52 (9) (2012) 1903–1910.
10] S.G. Wollenhaupt, et al., Seleno- and telluro-xylofuranosides attenuate
Mn-induced toxicity in C. elegans via the DAF-16/FOXO pathway, Food Chem.
Toxicol. 64 (2014) 192–199.
11] S.M. Salman, et al., CuO nano particles and [bmim]BF4: an application
towards the synthesis of chiral [small beta]-seleno amino derivatives via ring
opening reaction of aziridines with diorganyl diselenides, RSC Adv. 2 (22)
(2012) 8478–8482.
12] W.B. Wood, The Nematode Caenorhabditis elegans, Cold Spring Harbor
Laboratory Press, 1988, 2015.
13] P. Gubert, et al., Behavioral and metabolic effects of the atypical antipsychotic
ziprasidone on the nematode Caenorhabditis elegans, PLoS One 8 (9) (2013)
e74780.
14] E.L. Tsalik, O. Hobert, Functional mapping of neurons that control locomotory
behavior in Caenorhabditis elegans, J. Neurobiol. 56 (2) (2003) 178–197.
15] G.L. Ellman, et al., A new and rapid colorimetric determination of
acetylcholinesterase activity, Biochem. Pharmacol. 7 (2) (1961) 88–95.
16] R.D. Cole, G.L. Anderson, P.L. Williams, The nematode Caenorhabditis elegans
as  a model of organophosphate-induced mammalian neurotoxicity, Toxicol.
Appl. Pharmacol. 194 (3) (2004) 248–256.
17] M.M.  Bradford, A rapid and sensitive method for the quantitation of
microgram quantities of protein utilizing the principle of protein-dye binding,
Anal. Biochem. 72 (1-2) (1976) 248–254.
18] Clinical Laboratory Standards Institute, Methods for dilution antimicrobial
susceptibility tests for bacteria that grow aerobically: approved standard, in:
CLSI  document M7-A7, 7th ed., Wayne [PA]: Clinical and Laboratory
Standards Institute, 2006.
19] P. Brenneisen, H. Steinbrenner, H. Sies, Selenium, oxidative stress, and health
aspects, Mol. Aspects Med. 26 (4-5) (2005) 256–267.
20] L.V. Papp, et al., From selenium to selenoproteins: synthesis, identity, and
their role in human health, Antioxid Redox Signal. 9 (7) (2007) 775–806.
21] G. Mugesh, W.W.  du Mont, H. Sies, Chemistry of biologically important
synthetic organoselenium compounds, Chem. Rev. 101 (7) (2001) 2125–2179.
22] G. Mugesh, H.B. Singh, Synthetic organoselenium compounds as antioxidants:
glutathione peroxidase activity, Chem. Soc. Rev. 29 (5) (2000) 347–357.
23] A.S. Prestes, et al., Antioxidant activity of beta-selenoamines and their
capacity to mimic  different enzymes, Mol. Cell. Biochem. 365 (1-2) (2012)
85–92.
24] J.H. Thomas, Genetic analysis of defecation in Caenorhabditis elegans, Genetics
124 (4) (1990) 855–872.
25] L. Avery, The genetics of feeding in Caenorhabditis elegans, Genetics 133 (4)
(1993) 897–917.
26] C. Luchese, et al., Efﬁcacy of diphenyl diselenide against cerebral and
pulmonary damage induced by cadmium in mice, Toxicol. Lett. 173 (3) (2007)
181–190.
27] F. Martini, C.A. Brunning, S.M.C.W. Soares Nogueira, G. Zeni, Inhibitory effect
of  ebselen on cerebral acetylcholinesterase activity in vitro: kinetics and
reversibility of inhibition, Curr. Pharm. Des. 21 (7) (2014) 920–924.
ology R
[
[
[
[
[
[
[S.T. Stefanello et al. / Toxic
28] A. Strayer, et al., Expression of the small heat-shock protein Hsp-16-2 in
Caenorhabditis elegans is suppressed by Ginkgo biloba extract EGb 761, FASEB
J.  (2003).
29] E. de Castro, S. Hegi de Castro, T.E. Johnson, Isolation of long-lived mutants in
Caenorhabditis elegans using selection for resistance to juglone, Free Radic.
Biol. Med. 37 (2) (2004) 139–145.
30] A.J. Przybysz, et al., Increased age reduces DAF-16 and SKN-1 signaling and
the  hormetic response of Caenorhabditis elegans to the xenobiotic juglone,
Mech. Ageing Dev. 130 (6) (2009) 357–369.
31] J.J. Inbaraj, C.F. Chignell, Cytotoxic action of juglone and plumbagin: a
mechanistic study using HaCaT keratinocytes, Chem. Res. Toxicol. 17 (1)
(2003) 55–62.
[
[eports 2 (2015) 961–967 967
32] E. Stadtman, Protein oxidation and aging, Science 257 (5074) (1992)
1220–1224.
33] K.-L. Fong, et al., Evidence that peroxidation of lysosomal membranes is
initiated by hydroxyl free radicals produced during ﬂavin enzyme activity, J.
Biol. Chem. 248 (22) (1973) 7792–7797.
34] S. Bjelland, E. Seeberg, Mutagenicity, toxicity and repair of DNA base damage
induced by oxidation, Mutat Res. 531 (1-2) (2003) 37–80.35] S.T. Stefanello, et al., Effect of diselenide administration in
thioacetamide-induced acute neurological and hepatic failure in mice,
Toxicol. Res. 4 (3) (2015) 707–717.
36] H. Wójtowicz, et al., Azaanalogues of ebselen as antimicrobial and antiviral
agents: synthesis and properties, II Farmaco 59 (11) (2004) 863–868.
